Genomic testing in cancer treatment examines the tumor cells at the molecular level to use targeted medicines to seek out and destroy cancer cells based on their unique genetic makeup.
Alberto Montero, Co-Director, Breast Cancer Program at UH Seidman Cancer Center explains the value of genomic testing done initially at the time of the breast biopsy to give the team of cancer specialists the information they need to develop a personalized treatment plan for the patient.
To learn more: [ Ссылка ]
